这是一篇来自已证抗体库的有关人类 TJP2的综述，是根据47篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合TJP2 抗体。
TJP2 同义词: C9DUPq21.11; DFNA51; DUP9q21.11; PFIC4; X104; ZO2; tight junction protein ZO-2; Friedreich ataxia region gene X104 (tight junction protein ZO-2); zona occludens 2; zonula occludens protein 2

赛默飞世尔
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3s2a
赛默飞世尔 TJP2抗体（ThermoFisher, 711400)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3s2a). elife (2019) ncbi
兔 多克隆
  • proximity ligation assay; 狗; 1:100
  • 免疫细胞化学; 狗; 1:100; 图 1a
  • 免疫印迹; 狗; 1:1000; 图 1a
赛默飞世尔 TJP2抗体（Invitrogen, 711400)被用于被用于proximity ligation assay在狗样本上浓度为1:100, 被用于免疫细胞化学在狗样本上浓度为1:100 (图 1a) 和 被用于免疫印迹在狗样本上浓度为1:1000 (图 1a). Biochim Biophys Acta Mol Cell Res (2017) ncbi
兔 多克隆
  • 免疫印迹基因敲除验证; 大鼠; 图 4d
赛默飞世尔 TJP2抗体（GE医疗保健, 38-9100)被用于被用于免疫印迹基因敲除验证在大鼠样本上 (图 4d). Mol Biol Cell (2017) ncbi
兔 多克隆
  • 免疫细胞化学; 狗; 图 1A
赛默飞世尔 TJP2抗体（Invitrogen, 711400)被用于被用于免疫细胞化学在狗样本上 (图 1A). Mol Biol Cell (2016) ncbi
兔 多克隆
  • 免疫细胞化学; 人类; 1:50; 图 2b
  • 免疫印迹; 人类; 1:1000; 图 2a
赛默飞世尔 TJP2抗体（Invitrogen, 71-1400)被用于被用于免疫细胞化学在人类样本上浓度为1:50 (图 2b) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2a). Exp Cell Res (2015) ncbi
兔 多克隆
  • 免疫组化-冰冻切片; 小鼠; 1:200
赛默飞世尔 TJP2抗体（Invitrogen, 38-9,100)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:200. Mol Ther (2015) ncbi
兔 多克隆
  • 免疫细胞化学; 狗
赛默飞世尔 TJP2抗体（Invitrogen, 38-9100)被用于被用于免疫细胞化学在狗样本上. PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
赛默飞世尔 TJP2抗体（Invitrogen, 71-1400)被用于被用于免疫印迹在人类样本上. Eur J Pharm Biopharm (2015) ncbi
兔 多克隆
  • 免疫细胞化学; 小鼠; 1:500; 图 3
  • 免疫印迹; 小鼠; 1:500; 图 6
  • 免疫组化-石蜡切片; 大鼠; 1:500; 图 7
赛默飞世尔 TJP2抗体（Invitrogen, 71-1400)被用于被用于免疫细胞化学在小鼠样本上浓度为1:500 (图 3), 被用于免疫印迹在小鼠样本上浓度为1:500 (图 6) 和 被用于免疫组化-石蜡切片在大鼠样本上浓度为1:500 (图 7). Cell Cycle (2014) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:400
赛默飞世尔 TJP2抗体（Invitrogen, 71-1400)被用于被用于免疫组化在小鼠样本上浓度为1:400. Mol Vis (2014) ncbi
兔 多克隆
  • 免疫细胞化学; 狗
  • 免疫印迹; 狗
赛默飞世尔 TJP2抗体（Invitrogen, 38-9100)被用于被用于免疫细胞化学在狗样本上 和 被用于免疫印迹在狗样本上. PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫细胞化学; 小鼠; 1:100; 图 s5
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100 (图 s5). Cell Tissue Res (2014) ncbi
兔 多克隆
  • 免疫印迹; 狗
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于被用于免疫印迹在狗样本上. J Biol Chem (2014) ncbi
兔 多克隆
  • 免疫组化-冰冻切片; 小鼠; 1:100; 图 2
  • 免疫印迹; 小鼠; 1:1000; 图 1
赛默飞世尔 TJP2抗体（Invitrogen, 71-1400)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:100 (图 2) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1). Exp Cell Res (2013) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000
赛默飞世尔 TJP2抗体（Invitrogen, 38-9100)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Liver Int (2014) ncbi
小鼠 单克隆（3E8D9）
  • 免疫印迹; 人类; 1:1000
赛默飞世尔 TJP2抗体（Invitrogen, 37-4700)被用于被用于免疫印迹在人类样本上浓度为1:1000. Arch Dermatol Res (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
赛默飞世尔 TJP2抗体（Invitrogen, 71-1400)被用于被用于免疫印迹在人类样本上浓度为1:1000. Arch Dermatol Res (2014) ncbi
兔 多克隆
  • 免疫细胞化学; 狗; 1:100
赛默飞世尔 TJP2抗体（Invitrogen, 71-1400)被用于被用于免疫细胞化学在狗样本上浓度为1:100. J Virol (2013) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200; 图 7
赛默飞世尔 TJP2抗体（Invitrogen, 71-1400)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 7). Biol Open (2012) ncbi
兔 多克隆
  • 免疫组化-自由浮动切片; 小鼠; 1:50; 图 3
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于被用于免疫组化-自由浮动切片在小鼠样本上浓度为1:50 (图 3). Am J Physiol Renal Physiol (2013) ncbi
小鼠 单克隆（3E8D9）
  • 免疫细胞化学; 人类; 1:250; 图 7
  • 免疫印迹; 人类; 1:1000; 图 7
赛默飞世尔 TJP2抗体（Invitrogen, 3E8D9)被用于被用于免疫细胞化学在人类样本上浓度为1:250 (图 7) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 7). Am J Physiol Heart Circ Physiol (2012) ncbi
兔 多克隆
  • 免疫组化; 人类; 1:30; 图 2
赛默飞世尔 TJP2抗体（Invitrogen, 71-1400)被用于被用于免疫组化在人类样本上浓度为1:30 (图 2). BMC Gastroenterol (2012) ncbi
兔 多克隆
  • 免疫细胞化学; 小鼠; 图 2
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于被用于免疫细胞化学在小鼠样本上 (图 2). Stem Cells (2012) ncbi
兔 多克隆
  • 免疫组化; 大鼠; 图 5
赛默飞世尔 TJP2抗体（Invitrogen, 71-1400)被用于被用于免疫组化在大鼠样本上 (图 5). PLoS ONE (2012) ncbi
兔 多克隆
  • 免疫细胞化学; 狗; 图 2e
赛默飞世尔 TJP2抗体（Invitrogen, 71-1400)被用于被用于免疫细胞化学在狗样本上 (图 2e). Proc Natl Acad Sci U S A (2011) ncbi
兔 多克隆
  • 免疫组化-冰冻切片; 小鼠; 表 1
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于被用于免疫组化-冰冻切片在小鼠样本上 (表 1). Acta Neuropathol (2011) ncbi
兔 多克隆
  • 免疫细胞化学; 人类; 1:50; 图 1
赛默飞世尔 TJP2抗体（Invitrogen, 38-9000)被用于被用于免疫细胞化学在人类样本上浓度为1:50 (图 1). J Cell Mol Med (2012) ncbi
兔 多克隆
  • 免疫细胞化学; 小鼠; 图 1
赛默飞世尔 TJP2抗体（Invitrogen, 71-1400)被用于被用于免疫细胞化学在小鼠样本上 (图 1). Theriogenology (2011) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图 4
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于被用于免疫组化在小鼠样本上 (图 4). Antioxid Redox Signal (2011) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 图 s2
  • 免疫印迹; 小鼠; 图 s2
赛默飞世尔 TJP2抗体（Zymed, 38-9100)被用于被用于免疫组化在小鼠样本上 (图 s2) 和 被用于免疫印迹在小鼠样本上 (图 s2). J Invest Dermatol (2011) ncbi
兔 多克隆
  • 免疫沉淀; 狗; 图 3
  • 免疫细胞化学; 狗; 1:100; 图 4
  • 免疫印迹; 狗; 1:1000; 图 3
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于被用于免疫沉淀在狗样本上 (图 3), 被用于免疫细胞化学在狗样本上浓度为1:100 (图 4) 和 被用于免疫印迹在狗样本上浓度为1:1000 (图 3). Exp Cell Res (2010) ncbi
兔 多克隆
  • 免疫印迹; 羊; 1:5000
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于被用于免疫印迹在羊样本上浓度为1:5000. Am J Physiol Heart Circ Physiol (2010) ncbi
兔 多克隆
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于. Eur J Immunol (2008) ncbi
小鼠 单克隆（3E8D9）
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 TJP2抗体（Zymed Laboratories, 3E8D9)被用于被用于流式细胞仪在人类样本上 (图 4). Genome Biol (2008) ncbi
兔 多克隆
赛默飞世尔 TJP2抗体（Zymed, 71- 1400)被用于. Mol Membr Biol (2008) ncbi
小鼠 单克隆（3E8D9）
  • 免疫沉淀; 狗
赛默飞世尔 TJP2抗体（Zymed Laboratories, 37-4700)被用于被用于免疫沉淀在狗样本上. Mol Biol Cell (2007) ncbi
兔 多克隆
赛默飞世尔 TJP2抗体（Zymed Laboratories, 71-1400)被用于. Mol Biol Cell (2007) ncbi
兔 多克隆
赛默飞世尔 TJP2抗体（Zymed Laboratories, 71-1400)被用于. Exp Cell Res (2007) ncbi
兔 多克隆
赛默飞世尔 TJP2抗体（Invitrogen/Zymed, 71-1400)被用于. Neuroscience (2006) ncbi
兔 多克隆
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于. Mol Cancer Res (2004) ncbi
兔 多克隆
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于. J Cell Sci (2004) ncbi
兔 多克隆
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于. Exp Cell Res (2004) ncbi
兔 多克隆
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于. Can J Physiol Pharmacol (2004) ncbi
兔 多克隆
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于. Exp Cell Res (2004) ncbi
兔 多克隆
赛默飞世尔 TJP2抗体（Zymed, 71-1400)被用于. J Cell Biol (2001) ncbi
LifeSpan Biosciences
兔 多克隆
  • 免疫组化; 人类
  • 免疫印迹; 人类; 1:5000
LifeSpan Biosciences TJP2抗体（Source BioScience, LS-B2185)被用于被用于免疫组化在人类样本上 和 被用于免疫印迹在人类样本上浓度为1:5000. Nat Genet (2014) ncbi
赛信通（上海）生物试剂有限公司
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图 s8
赛信通（上海）生物试剂有限公司 TJP2抗体（Cell Signaling Technology, 2847)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s8). J Clin Invest (2016) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:100; 图 5b
  • 免疫印迹; 小鼠; 1:1000; 图 5f
赛信通（上海）生物试剂有限公司 TJP2抗体（Cell Signaling Technology, 2847)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 5b) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5f). Endocrinology (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠; 1:200; 图 7
赛信通（上海）生物试剂有限公司 TJP2抗体（Cell Signaling, 2847)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 7). Development (2015) ncbi
文章列表
  1. Fearnley G, Young K, Edgar J, Antrobus R, Hay I, Liang W, et al. The homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell-cell adhesion. elife. 2019;8: pubmed 出版商
  2. Raya Sandino A, Castillo Kauil A, Domínguez Calderón A, Alarcón L, Flores Benitez D, Cuellar Perez F, et al. Zonula occludens-2 regulates Rho proteins activity and the development of epithelial cytoarchitecture and barrier function. Biochim Biophys Acta Mol Cell Res. 2017;1864:1714-1733 pubmed 出版商
  3. Van Itallie C, Tietgens A, Anderson J. Visualizing the dynamic coupling of claudin strands to the actin cytoskeleton through ZO-1. Mol Biol Cell. 2017;28:524-534 pubmed 出版商
  4. Huang M, Liu T, Ma P, Mitteer R, Zhang Z, Kim H, et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J Clin Invest. 2016;126:1801-14 pubmed 出版商
  5. Domínguez Calderón A, Ávila Flores A, Ponce A, López Bayghen E, Calderón Salinas J, Luis Reyes J, et al. ZO-2 silencing induces renal hypertrophy through a cell cycle mechanism and the activation of YAP and the mTOR pathway. Mol Biol Cell. 2016;27:1581-95 pubmed 出版商
  6. Martínez Revollar G, Garay E, Martín Tapia D, Nava P, Huerta M, Lopez Bayghen E, et al. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Exp Cell Res. 2015;339:67-80 pubmed 出版商
  7. Dong H, Chen Z, Wang C, Xiong Z, Zhao W, Jia C, et al. Rictor Regulates Spermatogenesis by Controlling Sertoli Cell Cytoskeletal Organization and Cell Polarity in the Mouse Testis. Endocrinology. 2015;156:4244-56 pubmed 出版商
  8. Ghatak S, Chan Y, Khanna S, Banerjee J, Weist J, Roy S, et al. Barrier Function of the Repaired Skin Is Disrupted Following Arrest of Dicer in Keratinocytes. Mol Ther. 2015;23:1201-1210 pubmed 出版商
  9. Tokuda S, Furuse M. Claudin-2 knockout by TALEN-mediated gene targeting in MDCK cells: claudin-2 independently determines the leaky property of tight junctions in MDCK cells. PLoS ONE. 2015;10:e0119869 pubmed 出版商
  10. Grego Bessa J, Hildebrand J, Anderson K. Morphogenesis of the mouse neural plate depends on distinct roles of cofilin 1 in apical and basal epithelial domains. Development. 2015;142:1305-14 pubmed 出版商
  11. Watari A, Hashegawa M, Yagi K, Kondoh M. Homoharringtonine increases intestinal epithelial permeability by modulating specific claudin isoforms in Caco-2 cell monolayers. Eur J Pharm Biopharm. 2015;89:232-8 pubmed 出版商
  12. Qiao X, Roth I, Féraille E, Hasler U. Different effects of ZO-1, ZO-2 and ZO-3 silencing on kidney collecting duct principal cell proliferation and adhesion. Cell Cycle. 2014;13:3059-75 pubmed 出版商
  13. de Andrade G, Kunzelman L, Merrill M, Fuerst P. Developmentally dynamic colocalization patterns of DSCAM with adhesion and synaptic proteins in the mouse retina. Mol Vis. 2014;20:1422-33 pubmed
  14. Tokuda S, Higashi T, Furuse M. ZO-1 knockout by TALEN-mediated gene targeting in MDCK cells: involvement of ZO-1 in the regulation of cytoskeleton and cell shape. PLoS ONE. 2014;9:e104994 pubmed 出版商
  15. Steiner E, Enzmann G, Lyck R, Lin S, Ruegg M, Kroger S, et al. The heparan sulfate proteoglycan agrin contributes to barrier properties of mouse brain endothelial cells by stabilizing adherens junctions. Cell Tissue Res. 2014;358:465-79 pubmed 出版商
  16. Spadaro D, Tapia R, Jond L, Sudol M, Fanning A, Citi S. ZO proteins redundantly regulate the transcription factor DbpA/ZONAB. J Biol Chem. 2014;289:22500-11 pubmed 出版商
  17. Sambrotta M, Strautnieks S, Papouli E, Rushton P, Clark B, Parry D, et al. Mutations in TJP2 cause progressive cholestatic liver disease. Nat Genet. 2014;46:326-8 pubmed 出版商
  18. Hernández Monge J, Garay E, Raya Sandino A, Vargas Sierra O, Diaz Chavez J, Popoca Cuaya M, et al. Papillomavirus E6 oncoprotein up-regulates occludin and ZO-2 expression in ovariectomized mice epidermis. Exp Cell Res. 2013;319:2588-603 pubmed 出版商
  19. Chastre A, Belanger M, Nguyen B, Butterworth R. Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure. Liver Int. 2014;34:353-61 pubmed 出版商
  20. Siljamäki E, Raiko L, Toriseva M, Nissinen L, Näreoja T, Peltonen J, et al. p38? mitogen-activated protein kinase regulates the expression of tight junction protein ZO-1 in differentiating human epidermal keratinocytes. Arch Dermatol Res. 2014;306:131-41 pubmed 出版商
  21. Puerta Guardo H, Raya Sandino A, Gonzalez Mariscal L, Rosales V, Ayala Davila J, Chávez Mungía B, et al. The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability. J Virol. 2013;87:7486-501 pubmed 出版商
  22. Harrelson Z, Kaestner K, Evans S. Foxa2 mediates critical functions of prechordal plate in patterning and morphogenesis and is cell autonomously required for early ventral endoderm morphogenesis. Biol Open. 2012;1:173-81 pubmed 出版商
  23. Bautista García P, Reyes J, Martin D, Namorado M, Chavez Munguia B, Soria Castro E, et al. Zona occludens-2 protects against podocyte dysfunction induced by ADR in mice. Am J Physiol Renal Physiol. 2013;304:F77-87 pubmed 出版商
  24. Cheung T, Ganatra M, Peters E, Truskey G. Effect of cellular senescence on the albumin permeability of blood-derived endothelial cells. Am J Physiol Heart Circ Physiol. 2012;303:H1374-83 pubmed 出版商
  25. Monkemuller K, Wex T, Kuester D, Fry L, Kandulski A, Kropf S, et al. Role of tight junction proteins in gastroesophageal reflux disease. BMC Gastroenterol. 2012;12:128 pubmed 出版商
  26. Xu J, Lim S, Ng M, Ali S, Kausalya J, Limviphuvadh V, et al. ZO-1 regulates Erk, Smad1/5/8, Smad2, and RhoA activities to modulate self-renewal and differentiation of mouse embryonic stem cells. Stem Cells. 2012;30:1885-900 pubmed 出版商
  27. Géraud C, Evdokimov K, Straub B, Peitsch W, Demory A, Dörflinger Y, et al. Unique cell type-specific junctional complexes in vascular endothelium of human and rat liver sinusoids. PLoS ONE. 2012;7:e34206 pubmed 出版商
  28. Larre I, Castillo A, Flores Maldonado C, Contreras R, Galván I, Muñoz Estrada J, et al. Ouabain modulates ciliogenesis in epithelial cells. Proc Natl Acad Sci U S A. 2011;108:20591-6 pubmed 出版商
  29. Pfeiffer F, Schäfer J, Lyck R, Makrides V, Brunner S, Schaeren Wiemers N, et al. Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis. Acta Neuropathol. 2011;122:601-14 pubmed 出版商
  30. Mandel I, Paperna T, Glass Marmor L, Volkowich A, Badarny S, Schwartz I, et al. Tight junction proteins expression and modulation in immune cells and multiple sclerosis. J Cell Mol Med. 2012;16:765-75 pubmed 出版商
  31. Wang H, Luan L, Ding T, Brown N, Reese J, Paria B. Dynamics of zonula occludens-2 expression during preimplantation embryonic development in the hamster. Theriogenology. 2011;76:678-86 pubmed 出版商
  32. Coisne C, Engelhardt B. Tight junctions in brain barriers during central nervous system inflammation. Antioxid Redox Signal. 2011;15:1285-303 pubmed 出版商
  33. Kirschner N, Haftek M, Niessen C, Behne M, Furuse M, Moll I, et al. CD44 regulates tight-junction assembly and barrier function. J Invest Dermatol. 2011;131:932-43 pubmed 出版商
  34. Lechuga S, Alarcón L, Solano J, Huerta M, Lopez Bayghen E, Gonzalez Mariscal L. Identification of ZASP, a novel protein associated to Zona occludens-2. Exp Cell Res. 2010;316:3124-39 pubmed 出版商
  35. Sadowska G, Malaeb S, Stonestreet B. Maternal glucocorticoid exposure alters tight junction protein expression in the brain of fetal sheep. Am J Physiol Heart Circ Physiol. 2010;298:H179-88 pubmed 出版商
  36. Pfeiffer F, Kumar V, Butz S, Vestweber D, Imhof B, Stein J, et al. Distinct molecular composition of blood and lymphatic vascular endothelial cell junctions establishes specific functional barriers within the peripheral lymph node. Eur J Immunol. 2008;38:2142-55 pubmed 出版商
  37. Birnie R, Bryce S, Roome C, Dussupt V, Droop A, Lang S, et al. Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol. 2008;9:R83 pubmed 出版商
  38. Paschoud S, Citi S. Inducible overexpression of cingulin in stably transfected MDCK cells does not affect tight junction organization and gene expression. Mol Membr Biol. 2008;25:1-13 pubmed
  39. Huerta M, Munoz R, Tapia R, Soto Reyes E, Ramírez L, Recillas Targa F, et al. Cyclin D1 is transcriptionally down-regulated by ZO-2 via an E box and the transcription factor c-Myc. Mol Biol Cell. 2007;18:4826-36 pubmed
  40. Hernandez S, Chavez Munguia B, Gonzalez Mariscal L. ZO-2 silencing in epithelial cells perturbs the gate and fence function of tight junctions and leads to an atypical monolayer architecture. Exp Cell Res. 2007;313:1533-47 pubmed
  41. Ciolofan C, Li X, Olson C, Kamasawa N, Gebhardt B, Yasumura T, et al. Association of connexin36 and zonula occludens-1 with zonula occludens-2 and the transcription factor zonula occludens-1-associated nucleic acid-binding protein at neuronal gap junctions in rodent retina. Neuroscience. 2006;140:433-51 pubmed
  42. Bordin M, D Atri F, Guillemot L, Citi S. Histone deacetylase inhibitors up-regulate the expression of tight junction proteins. Mol Cancer Res. 2004;2:692-701 pubmed
  43. Guillemot L, Hammar E, Kaister C, Ritz J, Caille D, Jond L, et al. Disruption of the cingulin gene does not prevent tight junction formation but alters gene expression. J Cell Sci. 2004;117:5245-56 pubmed
  44. Jaramillo B, Ponce A, Moreno J, Betanzos A, Huerta M, Lopez Bayghen E, et al. Characterization of the tight junction protein ZO-2 localized at the nucleus of epithelial cells. Exp Cell Res. 2004;297:247-58 pubmed
  45. Dublineau I, Lebrun F, Grison S, Griffiths N. Functional and structural alterations of epithelial barrier properties of rat ileum following X-irradiation. Can J Physiol Pharmacol. 2004;82:84-93 pubmed
  46. Betanzos A, Huerta M, Lopez Bayghen E, Azuara E, Amerena J, Gonzalez Mariscal L. The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells. Exp Cell Res. 2004;292:51-66 pubmed
  47. Pálmer H, González Sancho J, Espada J, Berciano M, Puig I, Baulida J, et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol. 2001;154:369-87 pubmed